Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 46 of 59, showing 10 Applications out of 584 total, starting on record 451, ending on 460

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

451.

ECCT/22/08/03   NeoSep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of clinically diagnosed neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Christina Wesonga Obiero
2. James Alexander Berkley
Site(s) in Kenya
1. Kilifi County Hospital, KEMRI- Wellcome Trust Research Programme (KWTRP) (Kilifi county)
 
21-12-2022 View

452.

ECCT/17/08/09   A trial to compare two new combinations of antimalarial drugs with the standard combination of antimalarial drugs in Kenyan children
    An open-label randomised trial to assess the therapeutic efficacy and tolerability of arterolane-piperaquine plus single low dose primaquine versus arterolane-piperaquine plus mefloquine and single low dose primaquine versus artemether-lumefantrine plus single low dose primaquine in the treatment of uncomplicated falciparum malaria in children in Kenya.   
Principal Investigator(s)
1. Philip Bejon
Site(s) in Kenya
1. Kilifi County Hospital - Paediatric Out patient and Inpatient department (Kilifi county)
2. Pingilikani Dispensary (Kilifi county)
 
04-01-2018 View

453.

ECCT/25/01/01   FLORAL
    An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study.   
Principal Investigator(s)
1. Bernhard Ogutu
Site(s) in Kenya
1. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county)
2. Gertrude’s Children’s Hospital (Nairobi City county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county)
5. KEMRI WALTER REED KERICHO (Kericho county)
6. KEMRI Kondele Children\'s Hospital (Kisumu county)
7. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county)
 
24-04-2025 View

454.

ECCT/25/12/05   Floral Study
    An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study             
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. Kombewa Clinical Research Center (Kisumu county)
2. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county)
3. Gertrude\'s Children\'s Hospital (Nairobi City county)
4. KEMRI Siaya Clinical Research Annex (Siaya county)
5. KEMRI WALTER REED KERICHO (Kericho county)
6. KEMRI Kondele Children\'s Hospital (Kisumu county)
 
13-04-2026 View

455.

ECCT/19/04/03   Phase III pediatric study with the L-PZQ ODTs
    An Open-label, Phase 3 efficacy and safety study of L-praziquantel orodispersible tablets (L-PZQ ODT) in Schistosoma-infected children 3 months to 6 years of age, including a 2:1 randomized, controlled cohort of Schistosoma mansoni-infected children 4 to 6 years of age treated with L-PZQ ODT or commercial PZQ (Biltricide®)   
Principal Investigator(s)
1. Maurice Reuben Odiere
Site(s) in Kenya
KEMRI-Centre for Global Health Research (CGHR)
 
18-06-2019 View

456.

ECCT/12/08/01   Partners Demonstration Project
    An open-label, pilot demonstration and evaluation project of antiretrovira-based HIV-1 prevention among high-risk HIV-1 serodiscordant African couples.   
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
Site(s) in Kenya
1. Partners in Prevention, Thika Site (Kiambu county)
2. Partners in Prevention, Kisumu Site (Kisumu county)
 
01-10-2012 View

457.

ECCT/13/03/02   An open-label, pilot demonstration and evaluation project of antiretroviral-based HIV-1 prevention among high-risk HIV-1 serodiscordant African couples
    An open-label, pilot demonstration and evaluation project of antiretroviral-based HIV-1 prevention among high-risk HIV-1 serodiscordant African couples The Partners PrEP Study Demonstration Project   
Principal Investigator(s)
1. DR.ELIZABETH ANNE BUKUSI ELIZABETH ANNE BUKUSI
Site(s) in Kenya
1. THIKA (Nairobi City county)
 
10-07-2012 View

458.

ECCT/19/02/01   DANCE Study
    An Open-Label, Single Arm Study to Evaluate the Week 48 Efficacy and Safety of a Two-Drug Regimen of Dolutegravir/Lamivudine (DTG/3TC) as a Fixed Dose Combination (FDC), in Antiretroviral Therapy (ART)-Naive HIV-1-Infected Adolescents, ≥12 To <18 Years of Age who Weigh at Least 40 Kg.   
Principal Investigator(s)
1. Fredrick Odhiambo Otieno
2. Isaac Tsikhutsu
Site(s) in Kenya
1. Nyanza Reproductive Health Society (Kisumu county)
2. Kenya Medical Research Institute (Kisumu county)
3. Kenya Medical Research Institute, Walter Reed Project (Kericho county)
 
14-08-2019 View

459.

ECCT/16/12/01   The Partners Scale-Up Project
    Animplementation project to scale-up delivery of antiretroviral-based HIV-1 prevention amongKenyan HIV-1 serodiscordant couples.   
Principal Investigator(s)
1. Prof. Elizabeth Ann Bukusi
Site(s) in Kenya
1. KISUMU SITE (Kisumu county)
2. Thika Site (Kiambu county)
 
13-02-2017 View

460.

ECCT/17/07/01   ABCD
    Antibiotics for Children with Severe Diarrhea Trial   
Principal Investigator(s)
1. Judd Walson
Site(s) in Kenya
1. Rongo Sub-County Hospital (Migori county)
2. Ndhiwa Sub-County Hospital (Homa Bay county)
3. Rachuonyo Sub-County Hospital (Homa Bay county)
4. Isebania Sub-County Hospital (Migori county)
5. Awendo Sub-County Hospital (Migori county)
6. Mbita Sub-County Hospital (Homa Bay county)
 
01-12-2017 View